About US
Contact us
-
Vinay Prasad is back at the FDA after last month's surprise ouster. Will he stay this time?Vinay Prasad, M.D., has rejoined the FDA, the latest turn in a monthslong stretch of leadership turnover at the agency. “At the FDA’s request, Dr. Vinay Prasad is resuming leadership of the Center fo2025/7/31
-
Boehringer Ingelheim breaks into oncology with FDA approval for lung cancer med HernexeosWith the FDA approval of its zongertinibin certain non-small cell lung cancer (NSCLC) patients, 175-year-old Boehringer Ingelheim is entering the oncology market. Zongertinib, which will be sold as H2025/7/31
-
GSK collects $320M as BioNTech, Pfizer settle mRNA patent spat with CureVacThe chapter on Pfizer and BioNTech’s mRNA patent feud with Germany’s CureVac is coming to a close, even as lawsuits over the vaccine technology continue to play out on several other fronts. Pfizer an2025/7/29
-
Pfizer's integrated CMO adopts 'exclusive' mindset as it looks to redefine contract manufacturing partnerships: execContract manufacturers have carved out a lucrative niche within the biopharma industry, and the value of their collective capacity and production agility was on full display during the COVID-19 pande2025/7/29
-
Eli Lilly's Kisunla wins FDA nod for new dosing with fewer side effects in Alzheimer'sThe benefit-risk balance is tipping more in favor of Eli Lilly’s Kisunla in early Alzheimer’s disease as the FDAapprovesa new dosing regimen of the drug with an improved safety profile. The new recom2025/7/10
-
Southwest Airlines sues dozens of generic drugmakers for alleged price-fixing schemeSouthwest Airlines is buckling up to join in on a long-running legal battle surrounding an alleged price-fixing scheme involving generic medicines in the U.S. In a 730-page lawsuit filed in federal c2025/7/10
-
Novartis' malaria drug for babies wins world-first approvalNovartis and a Swiss nonprofit have made history, scoring the world’s first approval for a medicine to treat babies who are infected with malaria. Switzerland’s health regulator hassigned offon Coa2025/7/2
-
Achieve sparks up Omnicom pact, securing agency support for nicotine dependence drug launchAchieve Life Sciences hassigned upOmnicom to support the launch of nicotine dependence treatment cytisinicline, positioning the biotech to tap into capabilities at multiple agencies to reach patients2025/7/2
-
Dizal to challenge J&J with FDA approval for lung cancer drug ZegfrovyEight years after it wasestablishedpartly by AstraZeneca, Dizal Pharmaceuticals has gained its first FDAapproval, winning an accelerated nod for Zegfrovy (sunvozertinib) to become the only U.S.-endor2025/6/25
-
Amid $15B AstraZeneca partnership rumor, Summit needs $7.7B upfront to excite investors: analystAfter several PD-1xVEGF competitors forged alliances with Big Pharma players, Summit Therapeutics, the frontrunner in this hot cancer drug field, is reportedly seeking its own deal. AstraZeneca is in2025/6/17